These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 18368577

  • 1. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN, Akkuzu G, Ozgirgin N, Tarhan E.
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K, Schönfeld U, Clarke AH.
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [Abstract] [Full Text] [Related]

  • 3. Single-shot, low-dose intratympanic gentamicin in Ménière disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome.
    Gode S, Celebisoy N, Akyuz A, Gulec F, Karapolat H, Bilgen C, Kirazli T.
    Am J Otolaryngol; 2011 Dec; 32(5):412-6. PubMed ID: 20851502
    [Abstract] [Full Text] [Related]

  • 4. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I.
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [Abstract] [Full Text] [Related]

  • 5. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM, Hehar SS, Bance ML, Rutka JA.
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [Abstract] [Full Text] [Related]

  • 6. Does intratympanic gentamicin treatment for Meniere's disease cause complete vestibular ablation?
    Hone SW, Nedzelski J, Chen J.
    J Otolaryngol; 2000 Apr; 29(2):83-7. PubMed ID: 10819105
    [Abstract] [Full Text] [Related]

  • 7. VEMPs and dynamic posturography after intratympanic gentamycin in Menière's disease.
    Picciotti PM, Fiorita A, Di Nardo W, Quaranta N, Paludetti G, Maurizi M.
    J Vestib Res; 2005 Apr; 15(3):161-8. PubMed ID: 16179764
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM, Nedzelski JM, Chen JM, Shipp DB.
    Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
    [Abstract] [Full Text] [Related]

  • 15. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 16. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N, Boleas MS, Martin E.
    Audiol Neurootol; 2005 Feb; 10(2):69-78. PubMed ID: 15650298
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.